Cleared Traditional

K844146 - TOGGLE LOCKING PLIERS-STRAIGHT JAW, CURVED JAW (FDA 510(k) Clearance)

Class I General & Plastic Surgery device.

K844146 · Med-Tool, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1984
Decision
28d
Days
Class 1
Risk

K844146 is an FDA 510(k) clearance for the TOGGLE LOCKING PLIERS-STRAIGHT JAW, CURVED JAW. Classified as Pliers, Surgical (product code HTC), Class I - General Controls.

Submitted by Med-Tool, Inc. (Walker, US). The FDA issued a Cleared decision on November 20, 1984 after a review of 28 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4800 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Med-Tool, Inc. devices

Submission Details

510(k) Number K844146 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 23, 1984
Decision Date November 20, 1984
Days to Decision 28 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
86d faster than avg
Panel avg: 114d · This submission: 28d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HTC Pliers, Surgical
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 878.4800
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.